ImmUniverse Work Package 5 AD: Better control and treatment of Atopic Dermatitis disease by exploring the universe of microenvironment imposed tissue signatures and their correlates in liquid biopsies

ImmUniverse Work Package 5 AD: Better control and treatment of Atopic Dermatitis disease by exploring the universe of microenvironment imposed tissue signatures and their correlates in liquid biopsies - ImmUniverse WP5 AD

Status

Recruiting

Phases

Unknown

Study type

Interventional

Source

NL-OMON

Registry ID

NL-OMON49924

Enrollment

Registered

2022-01-12

Start date

2022-04-28

Completion date

Unknown

Last updated

2024-04-15

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

atopic dermatitis psoriasis

Interventions

Taking 2 biopsies. 1 of 3x3 mm and one of 4x4 mm. 3 extra tubes of blood are drawn during regular blood collection.

Eligibility

Age

18 Years to 64 Years

Inclusion criteria

Inclusion criteria: Diagnosis of Atopic Dermatitis or Psoriasis Age >= 18 years Provide signed informed consent

Exclusion criteria

Exclusion criteria: Age

Design outcomes

Primary

Measure	Time frame
The main aim of this project is to obtain a better control and treatment of immune-mediated diseases by exploring the universe of microenvironment imposed tissue signatures and their correlates in liquid biopsies	—

Secondary

Measure	Time frame
There is no secondary outcome of the study.	—

Countries

Netherlands

Outcome results

None listed

Source: NL-OMON (via WHO ICTRP)